Contribution of functional neuroimaging to understanding neuropsychiatric side effects of interferon in hepatitis C

Psychosomatics

Volumn 45, Issue 4, 2004, Pages 281-286

  Matthews, Scott C ^a,b   Paulus, Martin P ^a   Dimsdale, Joel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INTERFERON;

DEPRESSION; FATIGUE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; LIAISON PSYCHIATRY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PROPHYLAXIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 3042542925     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.45.4.281     Document Type: Review

References (28)

1. Bianchi G, Loguercio C, Sgarbi D, Abbiati R, Chen CH, Di Pierro M, Disalvo D, Natale S, Marchesini G: Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment. Dig Liver Dis 2000; 32:398-405
2. Lemer DM, Stoudemire A, Rosenstein DL: Neuropsychiatric toxicity associated with cytokine therapies. Psychosomatics 1999; 40:428-435
3. Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, Meyers CA, Howell CD: A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002; 7:942-947
4. Alberti A, Pontisso P: Hepatitis viruses as aetiological agents of hepatocellular carcinoma. Ital J Gastroenterol 1991; 23:452-456
5. Seeff LB: Natural history of hepatitis C. Hepatology 1997; 26(3 suppl 1):21S-28S
6. Fried MW: Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36(5 suppl 1):S237-S244
7. Dieperink E, Willenbring M, Ho SB: Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000; 157:867-876
8. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001; 344:961-966
9. Ogawa S, Lee TM, Kay AR, Tank DW: Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 1990; 87:9868-9872
10. Whalen PJ, Bush G, McNally RJ, Wilhelm S, McInerney SC, Jenike MA, Rauch SL: The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry 1998; 44:1219-1228
11. Critchley HD, Mathias CJ, Josephs O, O'Doherty J, Zanini S, Dewar BK, Cipolotti L, Shallice T, Dolan RJ: Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain 2003; 126:2139-2152
12. Matthews SC, Paulus MP, Simmons AN, Nelesen RA, Dimsdale JE: Functional subdivisions within anterior cingulate cortex and their relationship to autonomic nervous system function. Neuroimage (in press)
13. Bush G, Whalen PJ, Rosen BR, Jenike MA, McInerney SC, Rauch SL: The counting Stroop: an interference task specialized for functional neuroimaging; validation study with functional MRI. Human Brain Mapping 1998; 6:270-282
14. Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD: Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998; 280:747-749
15. Davidson RJ, Irwin W, Anderle MJ, Kalin NH: The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003; 160:64-75
16. Bechara A, Damasio AR, Damasio H, Anderson SW: Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50:7-15
17. Hikosaka K, Watanabe M: Delay activity of orbital and lateral prefrontal neurons of the monkey varying with different rewards. Cereb Cortex 2000; 10:263-271
18. Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB, Orr SP, Pitman RK: Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000; 47:769-776
19. Hariri AR, Mattay VS, Tessitore A, Fera F, Weinberger DR: Neocortical modulation of the amygdala response to fearful stimuli. Biol Psychiatry 2003; 53:494-501
20. Thomas KM, Drevets WC, Dahl RE, Ryan ND, Birmaher B, Eccard CH, Axelson D, Whalen PJ, Casey BJ: Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 2001; 58:1057-1063
21. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME: Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824-827
22. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT: Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 8:1057-1061
23. Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K: Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) 2000; 152:383-389
24. Schmaling KB, Lewis DH, Fiedelak JI, Mahurin R, Buchwald DS: Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome. Psychosom Med 2003; 65:129-136
25. Costa DC, Tannock C, Brostoff J: Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995; 88:767-773
26. Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, Ferlin G: Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105:54S-58S
27. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G: Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 2002; 15:559-567
28. Bush G, Shin LM, Holmes J, Rosen BR, Vogt BA: The Multi-Source Interference Task: validation study with fMRI in individual subjects. Mol Psychiatry 2003; 8:60-70